Michigan will Vote for Recreational Cannabis in November | CashCropToday
0 Shares 175 Views

Michigan will Vote for Recreational Cannabis in November

April 30, 2018
175 Views

The State Board of Canvassers in Michigan, the government body in the state that oversees its elections, has decided to include a recreational cannabis vote in the states November 2018 election.

Over 365,000 registered voters signed the petition in favor of the legalization of cannabis. If passed, adults the age of 21 and older would be able to carry up to 2.5 ounces of cannabis and the state would also collect a 10% tax on all marijuana sales.

Government officials are estimating that taxes from a legal industry could total $100 million a year. Michigan would become the 11th state in the U.S. to legalize adult use of the plant.

Though republican lawmakers in the state oppose the path to legalization, an advocacy group called the Coalition to Regulate Marijuana Like Alcohol believes that it is about time that the state considered marijuana legalization for adults because the generated tax dollars can help fix the states infrastructure and public education.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
269 views
Market Watch
269 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
192 views
Global
192 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
189 views
Manufacturing
189 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: